Dr. Steve Quay, Atossa Genetics (ATOS) Chairman & CEO

By John F. Heerdink, Jr. LinkedIn
 

Steven Quay Md, PhD

Chairman and CEO

View Linkedin Profile

“Atossa’s intraductal technology was invented by Dr. Love and subsequently acquired by Atossa. We are honored that Dr. Love has agreed to work with us on this important new study. This work begins as Atossa increases its corporate focus on its proprietary Endoxifen for the reduction of mammographic breast density.” READ the complete story here.


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us